STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

INFUSION News

NHIA Guidance for Addressing Shortages of Sodium Chloride 0.9% Injection Syringes for Flushing Venous Access Devices

In March 2022, the U.S. Food and Drug Administration released a Letter to Health Care Personnel alerting personnel that prefilled Sodium chloride 0.9% injection (NS) syringes are in shortage due to increased demand, supply chain challenges, and manufacturer discontinuation. NS syringes are used for flushing venous access devices (VADs)

Prefilled NS syringe shortages impact patient care, particularly for home infusion patients, and NHIA is continually addressing the ongoing shortage by working with manufacturers and suppliers, other professional health care organizations, and clinicians. Through these efforts, the association is staying up to date on the status of the shortages, collaborating to resolve them, and providing resources for managing the limited supply.  

NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.   

Download NHIA’s Guidance (pdf)

Guidance for Addressing Shortages of Sodium Chloride 0.9% Injection Syringes for Flushing Venous Access Devices

Related Posts

Considerations for Addressing ExactaMix Automated Compounding Device (ACD) Valve Set Supply Disruption

On April 19, 2022, Baxter announced a supply disruption of the ExactaMix valve sets (ExactaMix 1200 Valve Set H938792 and ExactaMix 2400 Valve Set H938724) due to raw material constraints that are impacting production volumes. As a result, healthcare providers and institutions are driven to consider conservation measures when compounding using the ExactaMix Automated Compounder.

Read More »

NHIA Releases Comments on California Senate Bill 958

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »